1. Kaur S, Pawar M, Banerjee N, Garg R. Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic nonhealing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: a randomized prospective controlled trial.
J Anaesthesiol Clin Pharmacol 2012;28:70-5.
2. Oter S, Korkmaz A, Topal T, et al. Correlation between hyperbaric oxygen exposure pressures and oxidative parameters in rat lung, brain, and erythrocytes.
Clin Biochem 2005;38:706-11.
3. Benedetti S, Lamorgese A, Piersantelli M, et al. Oxidative stress and antioxidant status in patients undergoing prolonged exposure to hyperbaric oxygen.
Clin Biochem 2004;37:312-7.
4. Dennog C, Radermacher P, Barnett YA, Speit G. Antioxidant status in humans after exposure to hyperbaric oxygen.
Mutat Res 1999;428:83-9.
5. Palmquist BM, Philipson B, Barr PO. Nuclear cataract and myopia during hyperbaric oxygen therapy.
Br J Ophthalmol 1984;68:113-7.
6. Tokarz P, Kaarniranta K, Blasiak J. Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD).
Biogerontology 2013;14:461-82.
7. Shoham A, Hadziahmetovic M, Dunaief JL, et al. Oxidative stress in diseases of the human cornea.
Free Radic Biol Med 2008;45:1047-55.
8. Arnal E, Peris-Martinez C, Menezo JL, et al. Oxidative stress in keratoconus?
Invest Ophthalmol Vis Sci 2011;52:8592-7.
9. Mozaffarieh M, Grieshaber MC, Flammer J. Oxygen and blood flow: players in the pathogenesis of glaucoma.
Mol Vis 2008;14:224-33.
10. Ferreira SM, Lerner SF, Brunzini R, et al. Antioxidant status in the aqueous humour of patients with glaucoma associated with exfoliation syndrome. Eye (Lond) 2009;23:1691-7.
11. Zhou L, Li Y, Yue BY. Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells from an ocular tissue: the trabecular meshwork.
J Cell Physiol 1999;180:182-9.
12. Li AF, Tane N, Roy S. Fibronectin overexpression inhibits trabecular meshwork cell monolayer permeability.
Mol Vis 2004;10:750-7.
13. Londahl M. Hyperbaric oxygen therapy as adjunctive treatment of diabetic foot ulcers.
Med Clin North Am 2013;97:957-80.
14. Johnston BR, Ha AY, Brea B, Liu PY. The mechanism of hyperbaric oxygen therapy in the treatment of chronic wounds and diabetic foot ulcers. R I Med J 2013 2016;99:26-9.
15. Stoekenbroek RM, Santema TB, Legemate DA, et al. Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review.
Eur J Vasc Endovasc Surg 2014;47:647-55.
16. Evanger K, Haugen OH, Irgens A, et al. Ocular refractive changes in patients receiving hyperbaric oxygen administered by oronasal mask or hood.
Acta Ophthalmol Scand 2004;82:449-53.
17. Plafki C, Peters P, Almeling M, et al. Complications and side effects of hyperbaric oxygen therapy.
Aviat Space Environ Med 2000;71:119-24.
18. Friedman DS, O’Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States.
Arch Ophthalmol 2004;122:564-72.
19. Sacca SC, Izzotti A, Rossi P, Traverso C. Glaucomatous outflow pathway and oxidative stress.
Exp Eye Res 2007;84:389-99.
20. Chrysostomou V, Rezania F, Trounce IA, Crowston JG. Oxidative stress and mitochondrial dysfunction in glaucoma.
Curr Opin Pharmacol 2013;13:12-5.
21. Izzotti A, Sacca SC, Longobardi M, Cartiglia C. Mitochondrial damage in the trabecular meshwork of patients with glaucoma.
Arch Ophthalmol 2010;128:724-30.
22. Caballero M, Liton PB, Epstein DL, Gonzalez P. Proteasome inhibition by chronic oxidative stress in human trabecular meshwork cells.
Biochem Biophys Res Commun 2003;308:346-52.
23. Fuchshofer R, Yu AH, Welge-Lussen U, Tamm ER. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells.
Invest Ophthalmol Vis Sci 2007;48:715-26.
24. Nucci C, Di Pierro D, Varesi C, et al. Increased malondialdehyde concentration and reduced total antioxidant capacity in aqueous humor and blood samples from patients with glaucoma.
Mol Vis 2013;19:1841-6.
25. Mousa A, Kondkar AA, Al-Obeidan SA, et al. Association of total antioxidants level with glaucoma type and severity.
Saudi Med J 2015;36:671-7.
26. Gallin-Cohen PF, Podos SM, Yablonski ME. Oxygen lowers intraocular pressure.
Invest Ophthalmol Vis Sci 1980;19:43-8.
27. Bojic L, Kovacevic H, Andric D, et al. Hyperbaric oxygen dose of choice in the treatment of glaucoma.
Arh Hig Rada Toksikol 1993;44:239-47.
28. Bojic L, Racic G, Gosovic S, Kovacevic H. The effect of hyperbaric oxygen breathing on the visual field in glaucoma. Acta Ophthalmol (Copenh) 1993;71:315-9.
29. Ersanli D, Akin T, Yildiz S, et al. The effect of hyperbaric oxygen on intraocular pressure.
Undersea Hyperb Med 2006;33:1-4.
30. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review.
J Biochem Mol Toxicol 2003;17:24-38.
31. Matough FA, Budin SB, Hamid ZA, et al. The role of oxidative stress and antioxidants in diabetic complications.
Sultan Qaboos Univ Med J 2012;12:5-18.
32. Vafa M, Mohammadi F, Shidfar F, et al. Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients.
Int J Prev Med 2012;3:531-6.
33. Opara EC. Role of oxidative stress in the etiology of type 2 diabetes and the effect of antioxidant supplementation on glycemic control.
J Investig Med 2004;52:19-23.
34. Al-Maskari MY, Waly MI, Ali A, et al. Folate and vitamin B12 deficiency and hyperhomocysteinemia promote oxidative stress in adult type 2 diabetes. Nutrition 2012;28:e23-6.
35. Ko ML, Peng PH, Hsu SY, Chen CF. Dietary deficiency of vitamin E aggravates retinal ganglion cell death in experimental glaucoma of rats.
Curr Eye Res 2010;35:842-9.
36. Ramdas WD, Wolfs RC, Kiefte-de Jong JC, et al. Nutrient intake and risk of open-angle glaucoma: the Rotterdam Study.
Eur J Epidemiol 2012;27:385-93.
37. Patel S, Mathan JJ, Vaghefi E, Braakhuis AJ. The effect of flavonoids on visual function in patients with glaucoma or ocular hypertension: a systematic review and meta-analysis.
Graefes Arch Clin Exp Ophthalmol 2015;253:1841-50.
38. Hodges LC, Kearse CE, Green K. Intraocular pressure-lowering activity of phenolic antioxidants in normotensive rabbits.
Curr Eye Res 1999;19:234-40.
39. Ayata A, Uzun G, Mutluoglu M, et al. Influence of hyperbaric oxygen therapy on central corneal thickness.
Ophthalmic Res 2012;47:19-22.
40. Guy J, Schatz NJ. Hyperbaric oxygen in the treatment of radiation-induced optic neuropathy.
Ophthalmology 1986;93:1083-8.
41. Borruat FX, Schatz NJ, Glaser JS, et al. Visual recovery from radiation-induced optic neuropathy. The role of hyperbaric oxygen therapy.
J Clin Neuroophthalmol 1993;13:98-101.
42. Bojic L, Ivanisevic M, Gosovic G. Hyperbaric oxygen therapy in two patients with non-arteritic anterior optic neuropathy who did not respond to prednisone.
Undersea Hyperb Med 2002;29:86-92.
43. Bennett M, Heard R. Hyperbaric oxygen therapy for multiple sclerosis.
Cochrane Database Syst Rev 2004;1:CD003057.